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Atrioventricular junction ablation as a bridging treatment 
of tachycardiomyopathy and renal insufficiency in the course 
of atrial fibrillation with high frequency ventricular rhythm
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Abstract
We present the case of a 67 year-old woman with tachycardiomyopathy induced by atrial fibrillation with high frequency 
ventricular response. The patient underwent resynchronisation pacemaker implantation and atrioventricular junction 
ablation as a bridging therapy prior to cryoballoon pulmonary vein ostia ablation.
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Introduction
Cardiomyopathy-induced arrhythmia is an important cau-
se of cardiac insufficiency. However, the heart damage it 
causes is potentially reversible. One of the arrhythmias 
that can lead to tachycardia is atrial fibrillation (AF) 
with a rapid ventricular rhythm. There are several tre-
atments to control both the type of rhythm and the rate 
of ventricular rhythms in patients with atrial fibrillation: 
pharmacotherapy, cardioversion, and ablation. Invasive 
procedures are undoubtedly the most effective in both the 
long- and the short-term. Both pulmonary vein ablation 
and atrioventricular junction ablation with implantation 
of a pacemaker system are extremely effective in this 
regard. Hybridising the two treatments can be an unusual 
practical solution.
Case report
A 67 year-old woman with no history of cardiovascular di-
sease was referred to the Department of Cardiology of the 
Regional Hospital due to her first-ever clinically apparent 
AF episode. Despite the use of full antiarrhythmic treat-
ment, i.e. full dose beta-blocker, amiodarone, digitalis, and 
calcium channel blockers in the initial phase, ventricular 
rhythm could not be returned to acceptable values. She 
presented with heart palpitations and symptoms of severe 
heart failure in New York Heart Association (NYHA) classes 
III and IV. Left ventricular ejection fraction (LVEF) decreased 
to 37%, functional mitral regurgitation aggravated to severe, 
progressive enlargement of left atrial (LA) artery eventu-
ally reached 39 cm2 and left ventricular diastolic diameter 
4.7 cm, impairment of right ventricular systolic function with 
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the patient’s condition, resolution of circulatory insufficien-
cy, and a further decline of pro-BNP. Thus, the patient was 
qualified to pulmonary veins isolation, and a cryoballoon 
ablation was performed. Amiodarone was discontinued 
after the successful procedure. For more than 24 months 
thereafter she has had no AF episodes, something which 
has been confirmed by CRT-P event tracking. The symp-
toms of circulatory failure have disappeared, creatinine 
level has dropped to 0.79 mg/dL, mitral regurgitation has 
improved to small, enlargement of LA to 35 cm2 persists, 
and N-terminal pro-B-type natriuretic peptide (NT-proBNP) 
levels remain low.
Discussion
There are many arrhythmias responsible for inducing ta-
chycardiomyopathy. The best form of treatment, if possible, 
is to remove the arrhythmia [1–5]. Effective treatment of 
arrhythmia usually results in complete resolution of left 
ventricular dysfunction [1]. An early drop in NT-proBNP level, 
reduced symptoms after the restoration of sinus rhythm, 
initially smaller left ventricular diastolic size, and a lack 
of late enhancements in magnetic resonance imaging 
(MRI) are all positive predictors of the total reversibility of 
ventricular dysfunction [2].
In the case in question, due to the presence of a throm-
bus in the left atrial appendage despite aggressive anti-
thrombotic treatment, directly targeted restoration of sinus 
rhythm, such as pulmonary veins isolation or rhythm car-
dioversion, was impossible. The circulation improvement 
obtained due to ablation of the atrioventricular junction 
contributed undoubtedly to the resolution of the previous 
thrombus. Because it was unclear whether the residual 
symptoms of heart failure were the effect of suboptimal 
stimulation, electric cardioversion of persistent AF was 
performed. Due to the high risk of AF recurring in patients 
lowest tricuspidal annular plane systolic excursion (TAPSE) 
of 1.3 cm, and the deteriorating renal function prevailed 
with a lowest glomerular filtration rate (GFR) of 23.4 mL/ 
/min/1.73 m2. Secondary causes of AF and lack of ventricu-
lar rate control were excluded. Despite adequate anti-clot-
ting treatment, the patient had a thrombus in the left atrial 
appendage, which persisted despite the intensification of 
treatment, making it impossible to perform both electrical 
cardioversion and ablation of AF. Despite the pharmacolo-
gical treatment, her condition deteriorated significantly, the 
symptoms of cachexia due to cardiac insufficiency started 
to develop, and the level of pro-B-type natriuretic peptide 
(proBNP) reached over 11,000, while creatinine increased 
to 2.22 mg/dL (Figure 1). Considering the above, she was 
qualified for cardiac resynchronisation therapy with a pace-
maker (CRT-P) with subsequent atrioventricular junction 
ablation as an alternative to control the ventricular rate. 
Unfortunately, no successful stimulation was achieved 
on the whole course of the posterior and postero-lateral 
cardiac veins. Ultimately a ‘left chamber’ electrode was 
implanted into the anterior vein of the heart. After the 
wound healing process and the confirmation of proper 
pacemaker function, an atrioventricular ablation procedure 
was performed, resulting in a very rapid improvement of 
the patient’s clinical status: a reduction of NYHA class 
symptoms, a decrease in creatinine level to 1.19 mg/dL, 
a systolic LVEF increase to 55%, a decrease in LA size, mi-
tral regurgitation improved to mild, a decrease of pro-BNP, 
and a gradual cessation of cachexia. The frequency of 
ventricular stimulation in the VVIR BiV mode with an initial 
output of 110 bpm was gradually reduced to 70 bpm.
Nevertheless, NYHA II class symptoms persisted. 
A control transoesophageal study found that a previously 
observed thrombus in the left atrial appendage had re-
solved. Electrical cardioversion was performed, obtaining 
restoration of sinus rhythm and a further improvement of 
Figure 1. Average frequency of ventricular rhythm and pro-B-type natriuretic peptide (proBNP) level during course of treatment; AF — atrial 
fibrillation; CRT-P — cardiac resynchronisation therapy with pacemaker; AV — atrioventricular
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with arrhythmia-induced cardiomyopathy, a risk that is 
associated with the poor prognosis of this group [5], the 
patient underwent cryoballoon pulmonary veins isolation.
It is worth noting that the treatment described resulted 
in normalisation of left ventricle function, inverse left atrium 
remodelling, withdrawal of mitral regurgitation, resolution 
of right ventricular systolic insufficiency, significantly decre-
ased pro-BNP, and normalised creatinine level.
Undoubtedly, in view of the increasing availability of His 
bundle pacing, such a procedure, especially in relation to 
the suboptimal position of the ‘left chamber’ pacing elec-
trode, might have been a better solution.
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Streszczenie
W pracy przedstawiono przypadek 67-letniej chorej z tachykardiomiopatią w przebiegu migotania przedsionków z szyb-
kim rytmem komór leczoną implantacją stymulatora resynchronizującego i ablacją łącza przedsionkowo-komorowego 
jako terapią pomostową przed krioablacją balonową ujść żył płucnych.
Słowa kluczowe: tachykardiomiopatia, migotanie przedsionków, ablacja łącza przedsionkowo-komorowego, terapia 
pomostowa
Folia Cardiologica 2019; 14, 6: 603–605
References
1. Twidale N, Sutton K, Bartlett L, et al. Effects on cardiac performance of 
atrioventricular node catheter ablation using radiofrequency current 
for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol. 1993; 
16(6): 1275–1284, doi: 10.1111/j.1540-8159.1993.tb01714.x, inde-
xed in Pubmed: 7686657.
2. Nia AM, Gassanov N, Dahlem KM, et al. Diagnostic accuracy of 
NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-media-
ted cardiomyopathy: a pilot study. Clin Res Cardiol. 2011; 100(10): 
887–896, doi: 10.1007/s00392-011-0319-y, indexed in Pubmed: 
21538234.
3. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial 
of catheter ablation versus medical treatment of atrial fibrillation 
in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 
2014; 7(1): 31–38, doi: 10.1161/CIRCEP.113.000806, indexed in 
Pubmed: 24382410.
4. Khan MN, Jaïs P, Cummings J, et al. PABA-CHF Investigators. Pulmo-
nary-vein isolation for atrial fibrillation in patients with heart failure. 
N Engl J Med. 2008; 359(17): 1778–1785, doi: 10.1056/NEJM-
oa0708234, indexed in Pubmed: 18946063.
5. Di Biase L, Mohanty P, Mohanty S, et al. Ablation versus amiodarone 
for treatment of persistent atrial fibrillation in patients with congestive 
heart failure and an implanted device: results from the AATAC mul-
ticenter randomized trial. Circulation. 2016; 133(17): 1637–1644, 
doi: 10.1161/CIRCULATIONAHA.115.019406, indexed in Pubmed: 
27029350.
6. Nerheim P, Birger-Botkin S, Piracha L, et al. Heart failure and sud-
den death in patients with tachycardia-induced cardiomyopathy 
and recurrent tachycardia. Circulation. 2004; 110(3): 247–252, 
doi: 10.1161/01.CIR.0000135472.28234.CC, indexed in Pubmed: 
15226218.
